+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic significance of mitochondrial oxidative phosphorylation complexes: Therapeutic target in the treatment of retinoblastoma



Prognostic significance of mitochondrial oxidative phosphorylation complexes: Therapeutic target in the treatment of retinoblastoma



Mitochondrion 23: 55-63



Altered energy metabolism plays an important role in the development and progression of cancer. The objective of this study was to elucidate the role of mitochondrial oxidative phosphorylation complexes and their prognostic significance in retinoblastoma (Rb). Immunohistochemistry was performed on 109 primary enucleated retinoblastoma tissues for mitochondrial OXPHOS complexes and their expression was confirmed by western blotting. Histopathological high risk factors (HRFs) were identified in 42.2% cases. Mitochondrial OXPHOS complexes III, IV and V were expressed in more than 50% of primary retinoblastoma cases each whereas mitochondrial complex I was expressed in only 29/109 (26.60%) cases by immunohistochemistry. Loss of mitochondrial complex I correlated well with poor tumor differentiation and tumor invasion (p < 0.05) whereas expression of mitochondrial complexes III, IV and V was associated with better survival (Kaplan-Meier method). This was the first study predicting a relevant role of mitochondrial OXPHOS complexes and highlights the prognostic significance with patient outcome in retinoblastoma. Loss of mitochondrial complex I immunoexpression could prove to be a useful independent prognostic biomarker to identify high risk retinoblastoma patients. Differential expression of these mitochondrial complexes is a novel finding and may be used as an attractive future anticancer target in primary retinoblastoma tumors. The author(s) have no proprietary or commercial interest in any materials discussed in this article.

(PDF emailed within 0-6 h: $19.90)

Accession: 058637208

Download citation: RISBibTeXText

PMID: 26071002

DOI: 10.1016/j.mito.2015.06.001


Related references

Human diseases with defects in oxidative phosphorylation: 1. Decreased amounts of assembled oxidative phosphorylation complexes in mitochondrial encephalomyopathies. European Journal of Biochemistry 227(3): 909-915, 1995

Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer. Cancers 10(9), 2018

Native electrophoresis for isolation of mitochondrial oxidative phosphorylation protein complexes. Methods in Enzymology 260: 190-202, 1995

Intrinsic protein kinase activity in mitochondrial oxidative phosphorylation complexes. Biochemistry 50(13): 2515-2529, 2011

Mitochondrial oxidative phosphorylation complexes exist in the sarcolemma of skeletal muscle. Bmb Reports 49(2): 116-121, 2016

Mitochondrial translation factor EF4 regulates oxidative phosphorylation complexes and the production of ROS. Free Radical Research 52(11-12): 1250-1255, 2019

Detection of protein thiols in mitochondrial oxidative phosphorylation complexes and associated proteins. Methods in Enzymology 474: 83-108, 2010

Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer. Bmc Medical Genetics 13(): 31-31, 2012

Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer. BMC Medical Genetics 13(1): 31, 2012

MtDNA T8993G mutation-induced mitochondrial complex V inhibition augments cardiolipin-dependent alterations of mitochondrial dynamics during oxidative, Ca2+ and lipid insults in NARP cybrids A potential therapeutic target for melatonin. 2011

mtDNA T8993G mutation-induced mitochondrial complex V inhibition augments cardiolipin-dependent alterations in mitochondrial dynamics during oxidative, Ca(2+), and lipid insults in NARP cybrids: a potential therapeutic target for melatonin. Journal of Pineal Research 52(1): 93-106, 2012

Evidence for physical association of mitochondrial fatty acid oxidation and oxidative phosphorylation complexes. Journal of Biological Chemistry 285(39): 29834-29841, 2010

A high-resolution method for assessing cellular oxidative phosphorylation efficiency: bringing mitochondrial bioenergetics into focus. Focus on "Direct real-time quantification of mitochondrial oxidative phosphorylation efficiency in permeabilized skeletal muscle myofibers". American Journal of Physiology. Cell Physiology 311(2): C237-C238, 2018

Proteins, polypeptides, prosthetic groups, and enzymic properties of complexes I, II, III, IV, and V of the mitochondrial oxidative phosphorylation system. Methods in Enzymology 56: 577-602, 1979

Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. Cancer Research 66(12): 6087-6096, 2006